Graviti Pharmaceuticals
Osmotic controlled-release tablet

Nitrograv OSM

Nifedipine

30 mg60 mg90 mg
Nitrograv OSM osmotic controlled-release tablet — Nifedipine
Indications

Hypertension and chronic stable angina requiring smooth 24-hour plasma coverage.

Composition

Each osmotic controlled-release tablet contains Nifedipine IP.

How we make it

Laser-drilled push-pull osmotic pump with 100% orifice inspection — one of our signature platforms.

This information is intended for healthcare professionals and trade partners. The brand name applies to Graviti's own branded generics range in India; in other markets the same formulation is supplied as a generic under our filings or a partner label. Prescribing information, registration status and pack availability vary by market. Medicines should be used only under qualified medical supervision.

Graviti line producing Nitrograv OSM

Nitrograv OSM — made to the same standard as every Graviti batch.